Inhibition of bradykinin-induced vasodilation in human forearm vasculature by icatibant, a potent B2-receptor antagonist.
about
Administration of angiotensin II and a bradykinin B2 receptor blocker in midpregnancy impairs gestational outcome in guinea pigs.Differences in vascular nitric oxide and endothelium-derived hyperpolarizing factor bioavailability in blacks and whites.Gene Variant of the Bradykinin B2 Receptor Influences Pulmonary Arterial Pressures in Heart Failure Patients.Venous occlusion plethysmography in cardiovascular research: methodology and clinical applicationsLocalization and expression of tissue kallikrein and kallistatin in human blood vessels.Metabolic control of muscle blood flow during exercise in humans.The effect of bradykinin B2 receptor polymorphisms on the susceptibility and severity of osteoarthritis in a Chinese cohortIcatibant, a new bradykinin-receptor antagonist, in hereditary angioedema.Role of the bradykinin B2 receptor in a rat model of local heart irradiation.Mechanisms of disease: the tissue kallikrein-kinin system in hypertension and vascular remodeling.Effects of bradykinin on venous capacitance in health and treated chronic heart failureAngiotensin-converting enzyme in skeletal muscle: sentinel of blood pressure control and glucose homeostasis.Endogenous bradykinin contributes to increased plasminogen activator inhibitor 1 antigen following hemodialysisACE inhibition enhances bradykinin relaxations through nitric oxide and B1 receptor activation in bovine coronary arteries.Therapeutic approaches in hereditary angioedema.Icatibant , the bradykinin B2 receptor antagonist with target to the interconnected kinin systems.Discovery and therapeutic potential of kinin receptor antagonists.Hereditary and acquired C1-inhibitor-dependent angioedema: from pathophysiology to treatment.Icatibant as acute treatment for hereditary angioedema in adults.The Story of Angioedema: from Quincke to Bradykinin.Icatibant.Role of blood flow in regulating insulin-stimulated glucose uptake in humans. Studies using bradykinin, [15O]water, and [18F]fluoro-deoxy-glucose and positron emission tomographyExercise-induced increase in interstitial bradykinin and adenosine concentrations in skeletal muscle and peritendinous tissue in humans.Bradykinin B1 receptor-mediated vasodilation is impaired in myometrial arteries from women with pre-eclampsia.Vasomotor and fibrinolytic responses to kinin receptor agonists in the atherosclerotic human lower limb.A severe case of Puumala hantavirus infection successfully treated with bradykinin receptor antagonist icatibant.Angiotensin converting enzyme defects in shock: implications for future therapy
P2860
Q33774507-A2497516-EBE5-4496-ADA8-F61F50BA04E7Q34068209-7E2A9FD8-A594-4287-83E6-9AF0D20593D7Q34201895-F86C9994-C2E1-45AB-9485-CA7AC8B69D66Q34459056-226DC381-3244-4073-A0C3-4BFB5C4AD865Q34487686-0617BCFB-8B39-49B8-BE3B-1307E80DD0F4Q35622623-48D1CE13-06DF-42F7-A9C5-9425230454B1Q36316032-918D258A-EC6D-4B0B-91C3-3F9F91D2A9B5Q36326043-77A4368A-1168-44BB-B20C-A55E98D78619Q36552117-1FAFD5E7-A78E-4FFE-A875-ABFFCA214CF6Q36772362-FEBC7E9E-041E-436D-831C-669BB1CF7484Q37084858-1EC8FEF7-2D3F-4C9D-911B-959A1869C64EQ37201619-719F4ACF-CBD0-48B8-A72D-ECF0E2A2934DQ37367707-E9D25B96-B443-4937-8575-9542C38AF08AQ37691451-0343FCD4-9E99-4E1C-B671-F6F27DCA2FA2Q37833531-C65A6DA4-D830-4719-9D28-D94CD18C2414Q38042696-E9D1ED37-2598-4E12-97AA-DF645A424F25Q38055254-17936B02-16E3-4F59-90B9-E5B79A41D279Q38790498-313F240C-CEB1-4DED-9DAF-0AB6EA9AE707Q38819740-2433CAB0-A8A0-4D71-903C-D0B46C9BA101Q38855032-F59EE4B5-55D4-41EE-8AA3-AEE154ABC586Q39293906-E1015D2C-EC15-4F12-945E-F6CF241B2815Q39763139-786A180E-3F2E-44D3-A138-E5BB9E51413CQ44087193-6FA3E7C3-66E5-4DCB-B6CF-4104F6B4615AQ45001014-583B45F2-815D-4D3E-8640-B86FE2F698AEQ45720876-92DC4528-81AC-461E-AB71-86D5592708ECQ46449890-58DD96E0-DB00-4124-A0B4-E48296BCFC5EQ58108305-7A925423-C06D-4489-AAE9-F65537027EE4
P2860
Inhibition of bradykinin-induced vasodilation in human forearm vasculature by icatibant, a potent B2-receptor antagonist.
description
1994 nî lūn-bûn
@nan
1994 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Inhibition of bradykinin-induc ...... potent B2-receptor antagonist
@nl
Inhibition of bradykinin-induc ...... potent B2-receptor antagonist.
@ast
Inhibition of bradykinin-induc ...... potent B2-receptor antagonist.
@en
type
label
Inhibition of bradykinin-induc ...... potent B2-receptor antagonist
@nl
Inhibition of bradykinin-induc ...... potent B2-receptor antagonist.
@ast
Inhibition of bradykinin-induc ...... potent B2-receptor antagonist.
@en
prefLabel
Inhibition of bradykinin-induc ...... potent B2-receptor antagonist
@nl
Inhibition of bradykinin-induc ...... potent B2-receptor antagonist.
@ast
Inhibition of bradykinin-induc ...... potent B2-receptor antagonist.
@en
P2093
P2860
P1476
Inhibition of bradykinin-induc ...... potent B2-receptor antagonist.
@en
P2093
Chowienczyk PJ
Cockcroft JR
P2860
P304
P356
10.1111/J.1365-2125.1994.TB04360.X
P407
P577
1994-10-01T00:00:00Z